Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials

October 2022 | Volume 21 | Issue 10 | 1084 | Copyright © October 2022


Published online September 22, 2022

John E. Jett PhD, Michael McLaughlin MS MSE, Timothy Wilson MS, Matthew C. Somerville MS, Wayne DellaMaestra MCS, David S. Rubenstein MD PhD, Stephen C. Piscitelli PharmD

Dermavant Sciences, Inc., Morrisville, NC